Research ArticleArticle
Follistatin-like Protein 1 and the Ferritin/Erythrocyte Sedimentation Rate Ratio Are Potential Biomarkers for Dysregulated Gene Expression and Macrophage Activation Syndrome in Systemic Juvenile Idiopathic Arthritis
Mark Gorelik, Ndate Fall, Mekibib Altaye, Michael G. Barnes, Susan D. Thompson, Alexei A. Grom and Raphael Hirsch
The Journal of Rheumatology May 2013, jrheum.121131; DOI: https://doi.org/10.3899/jrheum.121131
Mark Gorelik
From the Division of Rheumatology, Children’s Hospital of Pittsburgh, University of Pittsburgh Medical Center (UPMC), University of Pittsburgh, School of Medicine, Pittsburgh, Pennsylvania, USA. Supported in part by US National Institutes of Health grants R01-AI-073556, R01-AR-056959, and T32-AR-052282 to Dr. Hirsch; P01-AR048929 and P30 AR047363 to Dr. Thompson; and the Children’s Hospital of Pittsburgh, University of Pittsburgh Medical Center. M. Gorelik, MD; R. Hirsch MD, Division of Rheumatology, Children’s Hospital of Pittsburgh of UPMC, University of Pittsburgh, School of Medicine; N. Fall, MS; M.G. Barnes, PhD; S.D. Thompson, PhD; A.A. Grom, MD, William S. Rowe Division of Pediatric Rheumatology; M. Altaye, PhD, Division of Epidemiology and Biostatistics, Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio, USA. Address correspondence to Dr. M. Gorelik, Department of Pediatric Allergy and Immunology, Johns Hopkins Children’s Center, CMSC 1102, 600 N. Wolfe Street, Baltimore, MD 21287, USA. E-mail: mgoreli6@jhmi.edu Accepted for publication March 8, 2013.
Ndate Fall
From the Division of Rheumatology, Children’s Hospital of Pittsburgh, University of Pittsburgh Medical Center (UPMC), University of Pittsburgh, School of Medicine, Pittsburgh, Pennsylvania, USA. Supported in part by US National Institutes of Health grants R01-AI-073556, R01-AR-056959, and T32-AR-052282 to Dr. Hirsch; P01-AR048929 and P30 AR047363 to Dr. Thompson; and the Children’s Hospital of Pittsburgh, University of Pittsburgh Medical Center. M. Gorelik, MD; R. Hirsch MD, Division of Rheumatology, Children’s Hospital of Pittsburgh of UPMC, University of Pittsburgh, School of Medicine; N. Fall, MS; M.G. Barnes, PhD; S.D. Thompson, PhD; A.A. Grom, MD, William S. Rowe Division of Pediatric Rheumatology; M. Altaye, PhD, Division of Epidemiology and Biostatistics, Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio, USA. Address correspondence to Dr. M. Gorelik, Department of Pediatric Allergy and Immunology, Johns Hopkins Children’s Center, CMSC 1102, 600 N. Wolfe Street, Baltimore, MD 21287, USA. E-mail: mgoreli6@jhmi.edu Accepted for publication March 8, 2013.
Mekibib Altaye
From the Division of Rheumatology, Children’s Hospital of Pittsburgh, University of Pittsburgh Medical Center (UPMC), University of Pittsburgh, School of Medicine, Pittsburgh, Pennsylvania, USA. Supported in part by US National Institutes of Health grants R01-AI-073556, R01-AR-056959, and T32-AR-052282 to Dr. Hirsch; P01-AR048929 and P30 AR047363 to Dr. Thompson; and the Children’s Hospital of Pittsburgh, University of Pittsburgh Medical Center. M. Gorelik, MD; R. Hirsch MD, Division of Rheumatology, Children’s Hospital of Pittsburgh of UPMC, University of Pittsburgh, School of Medicine; N. Fall, MS; M.G. Barnes, PhD; S.D. Thompson, PhD; A.A. Grom, MD, William S. Rowe Division of Pediatric Rheumatology; M. Altaye, PhD, Division of Epidemiology and Biostatistics, Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio, USA. Address correspondence to Dr. M. Gorelik, Department of Pediatric Allergy and Immunology, Johns Hopkins Children’s Center, CMSC 1102, 600 N. Wolfe Street, Baltimore, MD 21287, USA. E-mail: mgoreli6@jhmi.edu Accepted for publication March 8, 2013.
Michael G. Barnes
From the Division of Rheumatology, Children’s Hospital of Pittsburgh, University of Pittsburgh Medical Center (UPMC), University of Pittsburgh, School of Medicine, Pittsburgh, Pennsylvania, USA. Supported in part by US National Institutes of Health grants R01-AI-073556, R01-AR-056959, and T32-AR-052282 to Dr. Hirsch; P01-AR048929 and P30 AR047363 to Dr. Thompson; and the Children’s Hospital of Pittsburgh, University of Pittsburgh Medical Center. M. Gorelik, MD; R. Hirsch MD, Division of Rheumatology, Children’s Hospital of Pittsburgh of UPMC, University of Pittsburgh, School of Medicine; N. Fall, MS; M.G. Barnes, PhD; S.D. Thompson, PhD; A.A. Grom, MD, William S. Rowe Division of Pediatric Rheumatology; M. Altaye, PhD, Division of Epidemiology and Biostatistics, Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio, USA. Address correspondence to Dr. M. Gorelik, Department of Pediatric Allergy and Immunology, Johns Hopkins Children’s Center, CMSC 1102, 600 N. Wolfe Street, Baltimore, MD 21287, USA. E-mail: mgoreli6@jhmi.edu Accepted for publication March 8, 2013.
Susan D. Thompson
From the Division of Rheumatology, Children’s Hospital of Pittsburgh, University of Pittsburgh Medical Center (UPMC), University of Pittsburgh, School of Medicine, Pittsburgh, Pennsylvania, USA. Supported in part by US National Institutes of Health grants R01-AI-073556, R01-AR-056959, and T32-AR-052282 to Dr. Hirsch; P01-AR048929 and P30 AR047363 to Dr. Thompson; and the Children’s Hospital of Pittsburgh, University of Pittsburgh Medical Center. M. Gorelik, MD; R. Hirsch MD, Division of Rheumatology, Children’s Hospital of Pittsburgh of UPMC, University of Pittsburgh, School of Medicine; N. Fall, MS; M.G. Barnes, PhD; S.D. Thompson, PhD; A.A. Grom, MD, William S. Rowe Division of Pediatric Rheumatology; M. Altaye, PhD, Division of Epidemiology and Biostatistics, Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio, USA. Address correspondence to Dr. M. Gorelik, Department of Pediatric Allergy and Immunology, Johns Hopkins Children’s Center, CMSC 1102, 600 N. Wolfe Street, Baltimore, MD 21287, USA. E-mail: mgoreli6@jhmi.edu Accepted for publication March 8, 2013.
Alexei A. Grom
From the Division of Rheumatology, Children’s Hospital of Pittsburgh, University of Pittsburgh Medical Center (UPMC), University of Pittsburgh, School of Medicine, Pittsburgh, Pennsylvania, USA. Supported in part by US National Institutes of Health grants R01-AI-073556, R01-AR-056959, and T32-AR-052282 to Dr. Hirsch; P01-AR048929 and P30 AR047363 to Dr. Thompson; and the Children’s Hospital of Pittsburgh, University of Pittsburgh Medical Center. M. Gorelik, MD; R. Hirsch MD, Division of Rheumatology, Children’s Hospital of Pittsburgh of UPMC, University of Pittsburgh, School of Medicine; N. Fall, MS; M.G. Barnes, PhD; S.D. Thompson, PhD; A.A. Grom, MD, William S. Rowe Division of Pediatric Rheumatology; M. Altaye, PhD, Division of Epidemiology and Biostatistics, Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio, USA. Address correspondence to Dr. M. Gorelik, Department of Pediatric Allergy and Immunology, Johns Hopkins Children’s Center, CMSC 1102, 600 N. Wolfe Street, Baltimore, MD 21287, USA. E-mail: mgoreli6@jhmi.edu Accepted for publication March 8, 2013.
Raphael Hirsch
From the Division of Rheumatology, Children’s Hospital of Pittsburgh, University of Pittsburgh Medical Center (UPMC), University of Pittsburgh, School of Medicine, Pittsburgh, Pennsylvania, USA. Supported in part by US National Institutes of Health grants R01-AI-073556, R01-AR-056959, and T32-AR-052282 to Dr. Hirsch; P01-AR048929 and P30 AR047363 to Dr. Thompson; and the Children’s Hospital of Pittsburgh, University of Pittsburgh Medical Center. M. Gorelik, MD; R. Hirsch MD, Division of Rheumatology, Children’s Hospital of Pittsburgh of UPMC, University of Pittsburgh, School of Medicine; N. Fall, MS; M.G. Barnes, PhD; S.D. Thompson, PhD; A.A. Grom, MD, William S. Rowe Division of Pediatric Rheumatology; M. Altaye, PhD, Division of Epidemiology and Biostatistics, Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio, USA. Address correspondence to Dr. M. Gorelik, Department of Pediatric Allergy and Immunology, Johns Hopkins Children’s Center, CMSC 1102, 600 N. Wolfe Street, Baltimore, MD 21287, USA. E-mail: mgoreli6@jhmi.edu Accepted for publication March 8, 2013.
Published eLetters
eLetters are comments published online only and are not peer-reviewed. Publication of eLetter submissions is not guaranteed, and all submissions are reviewed and edited at the discretion of The Journal's staff.
If you wish to publish Letters to the Editor or Correspondence, please submit through our online submission system ScholarOne Manuscripts.
Jump to comment:
No eLetters have been published for this article.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 3
1 Mar 2024
Follistatin-like Protein 1 and the Ferritin/Erythrocyte Sedimentation Rate Ratio Are Potential Biomarkers for Dysregulated Gene Expression and Macrophage Activation Syndrome in Systemic Juvenile Idiopathic Arthritis
Mark Gorelik, Ndate Fall, Mekibib Altaye, Michael G. Barnes, Susan D. Thompson, Alexei A. Grom, Raphael Hirsch
The Journal of Rheumatology May 2013, jrheum.121131; DOI: 10.3899/jrheum.121131
Follistatin-like Protein 1 and the Ferritin/Erythrocyte Sedimentation Rate Ratio Are Potential Biomarkers for Dysregulated Gene Expression and Macrophage Activation Syndrome in Systemic Juvenile Idiopathic Arthritis
Mark Gorelik, Ndate Fall, Mekibib Altaye, Michael G. Barnes, Susan D. Thompson, Alexei A. Grom, Raphael Hirsch
The Journal of Rheumatology May 2013, jrheum.121131; DOI: 10.3899/jrheum.121131